Open Access

Fyn expression is associated with the response of patients with locally advanced uterine cervical squamous cell carcinoma to neoadjuvant chemotherapy

  • Authors:
    • Shigenori Nanno
    • Takeshi Fukuda
    • Takuya Noda
    • Eijiro Uchikura
    • Yuichiro Awazu
    • Kenji Imai
    • Makoto Yamauchi
    • Tomoyo Yasui
    • Toshiyuki Sumi
  • View Affiliations

  • Published online on: August 11, 2022     https://doi.org/10.3892/mco.2022.2580
  • Article Number: 147
  • Copyright: © Nanno et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Neoadjuvant chemotherapy (NAC) followed by surgery is the current standard of treatment for locally advanced uterine cervical cancer; however, its value and outcomes remain contested. Identifying biomarkers that allow for the prediction of the effect of NAC efficacy before initiation of treatment is essential, in order to assist in choosing the optimum therapeutic regimen to maximize the beneficial outcomes of treatment. In the present retrospective study, 44 patients with locally advanced uterine cervical squamous cell carcinoma who underwent NAC were divided into two groups: A NAC successful group and a NAC failure group, depending on the efficacy of NAC. Subsequently, the association between Fyn expression, a non‑receptor tyrosine kinase that is a member of the Src family kinases, and NAC efficacy was determined; Fyn expression was detected by immunohistochemistry and assessed using a weighted scoring method. Additionally, the effect of Fyn knockdown on the sensitivity of a uterine cervical cancer cell line to cisplatin was determined. Notably, there were no significant differences between the two groups of patients regarding their characteristics. Regarding overall survival, the NAC successful group had a significantly longer survival time than the NAC failure group (P=0.01). Furthermore, the expression levels of Fyn in tumor tissues were significantly lower in the NAC successful group compared with those in the NAC failure group (P=0.003). The patients were subsequently divided into two groups (high expression group and low expression group) according to a cutoff value of 3, which was determined by producing a receiver operating characteristic curve from the weighted scores. The low expression group was significantly more sensitive to NAC than the high expression group (P<0.001). In vitro experiments revealed that Fyn knockdown significantly enhanced the sensitivity of uterine cancer cells to cisplatin (P<0.05). In conclusion, Fyn expression may be a potentially useful biomarker for predicting the response to NAC in patients with locally advanced uterine cervical squamous cell carcinoma, and may also be a promising molecular target for the management of uterine cancer.

Related Articles

Journal Cover

October-2022
Volume 17 Issue 4

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Nanno S, Fukuda T, Noda T, Uchikura E, Awazu Y, Imai K, Yamauchi M, Yasui T and Sumi T: Fyn expression is associated with the response of patients with locally advanced uterine cervical squamous cell carcinoma to neoadjuvant chemotherapy. Mol Clin Oncol 17: 147, 2022
APA
Nanno, S., Fukuda, T., Noda, T., Uchikura, E., Awazu, Y., Imai, K. ... Sumi, T. (2022). Fyn expression is associated with the response of patients with locally advanced uterine cervical squamous cell carcinoma to neoadjuvant chemotherapy. Molecular and Clinical Oncology, 17, 147. https://doi.org/10.3892/mco.2022.2580
MLA
Nanno, S., Fukuda, T., Noda, T., Uchikura, E., Awazu, Y., Imai, K., Yamauchi, M., Yasui, T., Sumi, T."Fyn expression is associated with the response of patients with locally advanced uterine cervical squamous cell carcinoma to neoadjuvant chemotherapy". Molecular and Clinical Oncology 17.4 (2022): 147.
Chicago
Nanno, S., Fukuda, T., Noda, T., Uchikura, E., Awazu, Y., Imai, K., Yamauchi, M., Yasui, T., Sumi, T."Fyn expression is associated with the response of patients with locally advanced uterine cervical squamous cell carcinoma to neoadjuvant chemotherapy". Molecular and Clinical Oncology 17, no. 4 (2022): 147. https://doi.org/10.3892/mco.2022.2580